Newsletter | July 21, 2021

07.21.21 -- Women's Health: Why More Investment Is Needed

The Economy Of The Future Is In Women’s Health

Recently, I was thinking a lot about the underinvestment in women’s health companies, technology breakthroughs for women’s issues, and sex differences in life sciences research and development efforts. Something has to change.

Life Sciences Faces Big Growth And Challenges

Overall, we believe that year-to-date performance of the industry is indicative of continued expansion throughout the year, with a focus on drug discovery and emerging therapies in biotechnology.

Against All Odds: Advancing From R&D To Phase 3

There is nothing more rewarding than knowing that we can help save a life and give hope to patients and their friends and families. Because lives are at stake, there must be more regulations and processes to ensure safety and efficacy.

First-Time CEOs: Firsthand Tales Of The Good, The Bad, And The Ugly

Since the CEO position comes with such high expectations and stress, we thought it would be interesting to speak with three first-time CEOs to hear their tales of the good, the bad, and the ugly. In this executive virtual roundtable (EVR), perspectives are provided by Roger Crystal, CEO, Opiant Pharmaceuticals, Frank Lee, CEO, Forma Therapeutics, and Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO, Vigil Neuroscience.

Special Edition #11: Making Diversity And Inclusion A Best Business Practice

Diversity and inclusion is — and has been — an important issue for the biopharmaceutical industry. As such, we thought it would be worthwhile to gain some perspective.

July 2021 Digital Edition

Inside you will find more on:

  • Travere's CEO Speaks
  • Biopharma Innovators
  • Closing The Health Leadership Gap
  • Decentralized Trials

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.